gene 739 words KG: GENEEXPRESSIONATLAS
Contents

Gene Expression Atlas

🧬 Gene Info
Gene SymbolGENEEXPRESSIONATLAS
AliasesGENEEXPRESSIONATLAS
[APP](/entities/app-protein)High expression in pyramidal neurons, moderate in interneurons
[MAPT](/proteins/tau) (Tau)High expression in pyramidal neurons; isoform expression shifts in AD
[APOE](/proteins/apoe)Expressed in astrocytes and microglia; APOE4 carriers show altered expression
[TREM2](/proteins/trem2)Microglia-specific expression; expression increases in AD
SNCAHigh expression in dopaminergic neurons; aggregation triggers cell death
GRNHigh expression in microglia; progranulin deficiency leads to TDP-43 pathology
[C9orf72](/entities/c9orf72)Moderate neuronal expression; hexanucleotide expansions cause toxicity
NEFL, NEFM (Neurofilament)Released in neurodegeneration; biomarkers
CLU (Clusterin)Astrocyte expression; clearance of debris
LRRK2Neuronal expression; kinase activity increases in disease
KG Connections2 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

NCBI GeneUniProtGeneCardsWikipediaHGNCEnsembl

Related Hypotheses (21)

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
APOE Isoform Conversion Therapy
Score: 0.72
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
CYP46A1 Overexpression Gene Therapy
Score: 0.77
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
APOE-TREM2 Interaction Modulation
Score: 0.74
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.66
TREM2-Dependent Microglial Senescence Transition
Score: 0.62
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.58
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.56
pg 1/2Next →

Related Analyses (10)

Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · archived

See Also (15)

Neurodegeneration
disease · KG edge: implicated_in
APOE4 (Apolipoprotein E4)
disease · Pages share 5 hypotheses
NCT07477431 - Levetiracetam for Persons at Risk for Alz
clinical · Pages share 5 hypotheses
UPenn Observational Research Repository (NCT04715399)
clinical · Pages share 5 hypotheses
APOE3 (Apolipoprotein E3)
disease · Pages share 5 hypotheses

Knowledge Graph (2 edges)

GENEEXPRESSIONATLAS data_in benchmark_ot_ad_answer_key:GENEEXPRESSIONATLAS
benchmark_ot_ad_answer_key:GENEEXPRESSIONATLAS data_in GENEEXPRESSIONATLAS

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.